Virology Journal,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: March 25, 2024
Abstract
Background
Several
observational
studies
demonstrated
that
pregnant
individuals
with
COVID-19
had
a
higher
risk
of
preeclampsia
and
preterm
birth.
We
aimed
to
determine
whether
women
diagnosis
adverse
pregnancy
outcomes.
Methods
A
two-sample
Mendelian
randomization
(MR)
analysis
in
this
study
was
used
evaluate
the
casual
relationships
between
infection
obstetric-related
diseases
based
on
genome-wide
association
(GWAS)
dataset.
Inverse-variance
weighted
(IVW),
MR-Egger
MR-PRESSO
were
infer
connection
estimate
pleiotropy
respectively.
Results
The
significant
observed
placental
disorders
beta
IVW
1.57
odds
ratio
(OR)
4.81
(95%
confidence
interval
[CI]:
1.05–22.05,
p
=
0.04).
However,
there
no
associations
gestational
diabetes
mellitus
(GDM)
(OR
1.12;
95%
CI:
0.85–1.45,
0.41),
other
amniotic
fluid
membranes
0.90;
0.61–1.32,
0.59),
Intrahepatic
Cholestasis
Pregnancy
(ICP)
1.42;
0.85–2.36,
0.18),
birth
weight
1.02;
0.99–1.05,
0.19),
hypertension
1.00;
1.00–1.00,
0.85),
spontaneous
miscarriages
0.96–1.04,
0.90)
stillbirth
0.98–1.01,
0.62).
Conclusion
There
direct
causal
relationship
maternal
neonatal
poor
Our
could
alleviate
anxiety
under
pandemic
conditions
partly.
JAMA,
Journal Year:
2022,
Volume and Issue:
327(8), P. 748 - 748
Published: Feb. 7, 2022
It
remains
unknown
whether
SARS-CoV-2
infection
specifically
increases
the
risk
of
serious
obstetric
morbidity.
To
evaluate
association
with
maternal
morbidity
or
mortality
from
common
complications.
Retrospective
cohort
study
14
104
pregnant
and
postpartum
patients
delivered
between
March
1,
2020,
December
31,
2020
(with
final
follow-up
to
February
11,
2021),
at
17
US
hospitals
participating
in
Eunice
Kennedy
Shriver
National
Institute
Child
Health
Human
Development's
Gestational
Research
Assessments
COVID-19
(GRAVID)
Study.
All
were
included
compared
those
without
a
positive
test
result
who
on
randomly
selected
dates
over
same
period.
was
based
nucleic
acid
antigen
result.
Secondary
analyses
further
stratified
by
disease
severity.
The
primary
outcome
composite
death
related
hypertensive
disorders
pregnancy,
hemorrhage,
other
than
SARS-CoV-2.
main
secondary
cesarean
birth.
Of
(mean
age,
29.7
years),
2352
had
11
752
did
not
have
Compared
result,
significantly
associated
(13.4%
vs
9.2%;
difference,
4.2%
[95%
CI,
2.8%-5.6%];
adjusted
relative
[aRR],
1.41
1.23-1.61]).
5
deaths
group.
birth
(34.7%
32.4%;
aRR,
1.05
0.99-1.11]).
moderate
higher
severity
(n
=
586)
(26.1%
16.9%
13.3%-20.4%];
2.06
1.73-2.46])
major
(45.4%
12.8%
8.7%-16.8%];
1.17
1.07-1.28]),
but
mild
asymptomatic
1766)
(9.2%
0%
-1.4%
1.4%];
1.11
0.94-1.32])
(31.2%
-3.6%
0.8%];
1.00
0.93-1.07]).
Among
individuals
hospitals,
an
increased
for
Med,
Journal Year:
2021,
Volume and Issue:
2(5), P. 591 - 610.e10
Published: April 30, 2021
BackgroundPregnant
women
are
at
increased
risk
for
severe
outcomes
from
coronavirus
disease
2019
(COVID-19),
but
the
pathophysiology
underlying
this
morbidity
and
its
potential
effect
on
developing
fetus
is
not
well
understood.MethodsWe
assessed
placental
histology,
ACE2
expression,
viral
immune
dynamics
term
placenta
in
pregnant
with
without
respiratory
acute
syndrome
2
(SARS-CoV-2)
infection.FindingsThe
majority
(13
of
15)
placentas
analyzed
had
no
detectable
RNA.
was
detected
by
immunohistochemistry
syncytiotrophoblast
cells
normal
during
early
pregnancy
rarely
seen
healthy
full
term,
suggesting
that
low
expression
may
protect
infection.
Using
immortalized
cell
lines
primary
isolated
cells,
we
found
cytotrophoblasts,
trophoblast
stem
precursors
to
syncytiotrophoblasts,
rather
than
syncytiotrophoblasts
or
Hofbauer
most
vulnerable
SARS-CoV-2
infection
vitro.
To
better
understand
mechanisms
shielding
vivo,
performed
bulk
single-cell
transcriptomics
analyses
maternal-fetal
interface
SARS-CoV-2-infected
exhibited
robust
responses,
including
activation
natural
killer
(NK)
T
interferon-related
genes,
as
markers
associated
complications
such
preeclampsia.ConclusionsSARS-CoV-2
late
even
absence
local
invasion.FundingNIH
(T32GM007205,
F30HD093350,
K23MH118999,
R01AI157488,
U01DA040588)
Fast
Grant
funding
support
Emergent
Ventures
Mercatus
Center.
BMC Pregnancy and Childbirth,
Journal Year:
2021,
Volume and Issue:
21(1)
Published: April 1, 2021
Abstract
Background
To
determine
whether
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2,
the
cause
of
COVID-19
disease)
exposure
in
pregnancy,
compared
to
non-exposure,
is
associated
with
infection-related
obstetric
morbidity.
Methods
We
conducted
a
multicentre
prospective
study
pregnancy
based
on
universal
antenatal
screening
program
for
SARS-CoV-2
infection.
Throughout
Spain
45
hospitals
tested
all
women
at
admission
delivery
ward
using
polymerase-chain-reaction
(PCR)
since
late
March
2020.
The
cohort
positive
mothers
and
concurrent
sample
negative
was
followed
up
until
6-weeks
post-partum.
Multivariable
logistic
regression
analysis,
adjusting
known
confounding
variables,
determined
adjusted
odds
ratio
(aOR)
95%
confidence
intervals
(95%
CI)
association
infection
outcomes.
Main
outcome
measures:
Preterm
(primary),
premature
rupture
membranes
neonatal
intensive
care
unit
admissions.
Results
Among
1009
screened
pregnancies,
246
were
positive.
Compared
(763
cases),
increased
preterm
birth
(34
vs
51,
13.8%
6.7%,
aOR
2.12,
CI
1.32–3.36,
p
=
0.002);
iatrogenic
more
frequent
infected
(4.9%
1.3%,
0.001),
while
occurrence
spontaneous
deliveries
statistically
similar
(6.1%
4.7%).
An
risk
term
(39
75,
15.8%
9.8%,
1.70,
1.11–2.57,
0.013)
admissions
(23
18,
9.3%
2.4%,
4.62,
2.43–8.94,
<
0.001)
also
observed
mothers.
Conclusion
This
demonstrated
that
pregnant
have
hypothesis
merits
evaluation
causal
further
research.
PLoS ONE,
Journal Year:
2021,
Volume and Issue:
16(8), P. e0255994 - e0255994
Published: Aug. 11, 2021
Introduction
The
association
between
Coronavirus
Disease
2019
(COVID-19)
and
abortion
has
been
debated
since
the
beginning
of
COVID-19
pandemic.
We
aimed
to
conduct
this
systematic
review
understand
better
potential
effects
Severe
Acute
Respiratory
Syndrome
2
(SARS-CoV-2)
on
fetal
loss
in
infected
mothers
presented
with
following
infection.
Methods
included
articles
published
PubMed/Medline,
Web
Science,
clinicaltrials.gov,
Embase
databases
2020
through
a
comprehensive
search
via
appropriate
keywords,
including
synonyms.
All
studies
data
confirmed
pregnant
females
were
collected.
Results
Out
208
potentially
relevant
articles,
11
eligible
include
review.
reports
because
reasons:
(1)
First-trimester
miscarriage;
(2)
Late
(3)
complication
infection
pregnancy;
(4)
disease
artificial
pregnancy.
was
found
5
studies,
second-trimester
7
studies.
Two
patients
acquired
during
hospital
stay
while
they
referred
for
abortion.
Reports
related
show
that
most
miscarriages
due
first
trimester
placental
insufficiency.
Conclusions
There
is
an
increased
risk
positive
test
result
SARS-CoV-2,
which
several
case
series
have
identified
Placental
inflammation
viral
may
growth
retardation
induce
not
any
consistent
evidence
vertical
transmission
virus
from
mother
fetus,
requires
further
investigation.
Obstetrics and Gynecology,
Journal Year:
2021,
Volume and Issue:
137(4), P. 585 - 596
Published: March 10, 2021
OBJECTIVE:
To
compare
the
risk
of
intrauterine
fetal
death
(20
weeks
gestation
or
later)
and
neonatal
among
individuals
who
tested
positive
for
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
compared
with
those
negative
SARS-CoV-2
on
admission
delivery.
DATA
SOURCES:
MEDLINE,
Ovid,
EMBASE,
Cumulative
Index
to
Nursing
Allied
Health,
Cochrane
Library
were
searched
from
their
inception
until
July
17,
2020.
Hand
search
additional
articles
continued
through
September
24,
ClinicalTrials.gov
was
October
21,
METHODS
OF
STUDY
SELECTION:
The
inclusion
criteria
publications
that
at
least
20
cases
both
pregnant
patients
labor
delivery
negative.
Exclusion
fewer
than
in
either
category
lacking
data
primary
outcomes.
A
systematic
selected
databases
performed,
co-primary
outcomes
being
rates
death.
Secondary
included
maternal
adverse
TABULATION,
INTEGRATION,
AND
RESULTS:
Of
941
completed
trials
identified,
six
studies
met
criteria.
Our
analysis
728
deliveries
3,836
contemporaneous
Intrauterine
occurred
8
(1.1%)
44
(
P
=.60).
Neonatal
0
432
(0.0%)
5
2,400
(0.2%)
=.90).
Preterm
birth
95
714
(13.3%)
446
3,759
(11.9%)
=.31).
Maternal
3
559
(0.5%)
3,155
(0.3%)
=.23).
CONCLUSION:
incidences
similar
when
admitted
Other
immediate
newborns
also
born
SARS-CoV-2.
SYSTEMATIC
REVIEW
REGISTRATION:
PROSPERO,
CRD42020203475.
Human Reproduction,
Journal Year:
2022,
Volume and Issue:
37(6), P. 1126 - 1133
Published: March 25, 2022
Does
maternal
infection
with
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
in
the
first
trimester
affect
risk
of
miscarriage
before
13
week's
gestation?
PEDIATRICS,
Journal Year:
2023,
Volume and Issue:
151(5)
Published: April 6, 2023
Long-term
neurodevelopmental
sequelae
are
a
potential
concern
in
neonates
following
utero
exposure
to
severe
acute
respiratory
syndrome
coronavirus
disease
2
(SARS-CoV-2).
We
report
born
SARS-CoV-2
positive
mothers,
who
displayed
early-onset
(day
1)
seizures,
acquired
microcephaly,
and
significant
developmental
delay
over
time.
Sequential
MRI
showed
parenchymal
atrophy
cystic
encephalomalacia.
At
birth,
neither
infant
was
(nasopharyngeal
swab,
reverse
transcription
polymerase
chain
reaction),
but
both
had
detectable
antibodies
increased
blood
inflammatory
markers.
Placentas
from
mothers
SARS-CoV-2-nucleocapsid
protein
spike
glycoprotein
1
the
syncytiotrophoblast,
fetal
vascular
malperfusion,
significantly
oxidative
stress
markers
pyrin
domain
containing
protein,
macrophage
βη,
stromal
cell-derived
factor
1,
interleukin
13,
10,
whereas
human
chorionic
gonadotropin
markedly
decreased.
One
(case
experienced
sudden
unexpected
death
at
13
months
of
age.
The
deceased
infant's
brain
evidence
by
immunofluorescence,
with
colocalization
nucleocapsid
around
nucleus
as
well
within
cytoplasm.
constellation
clinical
findings,
placental
pathology,
immunohistochemical
changes
strongly
suggests
that
second-trimester
maternal
infection
placentitis
triggered
an
response
injury
fetoplacental
unit
affected
brain.
demonstration
also
raises
possibility
directly
contributed
ongoing
injury.
In
infants,
neurologic
findings
birth
mimicked
presentation
hypoxic-ischemic
encephalopathy
newborn
progressed
beyond
neonatal
period.
Frontiers in Global Women s Health,
Journal Year:
2021,
Volume and Issue:
2
Published: Feb. 17, 2021
The
new
coronavirus
(SARS-Cov-2)
was
first
identified
in
late
2019
as
the
RNA
virus
coronaviridae
family
responsible
for
causing
COVID-19
residents
of
China's
Hubei
province.
In
mid-March
2020
WHO
declared
pandemic
caused
by
this
a
result
thousands
people
infected
all
over
world.
Epidemiological
evidence
obtained
from
other
pandemics,
such
influenza
and
ebola,
suggest
that
pregnant
women
are
more
susceptible
to
serious
complications
death
viral
infection.
Physiological
changes
anatomical
structure
respiratory
system
well
immune
during
pregnancy-puerperal
period
seem
contribute
greater
risk.
Thus,
be
SARS-COV-2
or
viruses
have
disease.
fact,
can
alter
responses
at
maternal-fetal
interface,
affecting
well-being
both
mother
her
fetus.
There
is
still
no
sufficient
literature
support
occurrence
vertical
transmission
through
breastfeeding,
but
prevalence
prematurity
high
among
SARS-Cov-2.
review,
may
increase
susceptibility
SARS-Cov-2
discussed
possible
mechanisms
involved
fetus
breastfeeding.